chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Oxygen saturation low; Night sweats; Diarrhea; Nausea; wheeze at the end of her exhale; severe headache; Fatigue; Chills; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient reported that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date, NDC number: Unknown), via an unspecified route of administration, administered in Arm Left on 06Mar2021 at 13:40 as 2nd dose, single for covid-19 immunization. Medical history included lipoedema (Adipose fat disorder) from 2017. The patient's concomitant medications was not reported. Historical vaccine of first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date, NDC number: Unknown), via an unspecified route of administration, administered in upper left shoulder on 13Feb2021 as 1ST DOSE, SINGLE, vaccinated at the age of 55 years for covid-19 immunization. She called about the covid vaccine and reported that she had no luck and had been sick for 10 days with sort of vaccine side effects and covid symptoms. All of the symptoms started 2 weeks after the second dose. On 14Mar2021, She had severe headache which was relieved by migraine medication, the headache came back when the medication wears off. On same day, she had chills. The chills have gone away. She also had a wheeze at the end of her exhale that she noticed really at night, she heard her breathing but did not know how to explain it. On 15Mar2021, she had nausea. Nausea improved when the headache went away. On 17Mar2021, She had diarrhea. The diarrhea went back and forth. 5 days ago on 18Mar2021, she started having night sweats but they happened early in the morning she wakes up in a puddle of sweat. On 19Mar2021, her oxygen saturation was low. It was reported that she had virtual doctors appointment. The patient's oxygen saturation was low on 17Mar2021 which was 90% lowest, 95% highest, she had been checking it at home with her pulse ox. On same day, she underwent sars-cov-2 antibody test which was negative. The outcome of severe headache, fatigue, Night sweats, Nausea, Diarrhea and Diarrhea was not recovered. Severe headache was reported as worsened. The outcome of Chills and Oxygen saturation low was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
stiff arm; swelling; severe diarrhea; nausea; headache; flu-like symptoms; pain/achiness; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), MUSCULOSKELETAL STIFFNESS (stiff arm), DIARRHOEA (severe diarrhea), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE PAIN (pain/achiness) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030H21B, 008B212A and 046BZIA or 046BZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Dec-2021 at 5:00 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, the patient experienced VACCINATION SITE PAIN (pain/achiness). On 07-Dec-2021 at 2:00 AM, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), DIARRHOEA (severe diarrhea), NAUSEA (nausea) and HEADACHE (headache). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff arm) and VACCINATION SITE SWELLING (swelling). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), MUSCULOSKELETAL STIFFNESS (stiff arm), DIARRHOEA (severe diarrhea), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (pain/achiness), NAUSEA (nausea) and HEADACHE (headache) had not resolved.      No concomitant medication was reported by the reporter. No treatment was reported by the reporter.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not provided. On 11-DEC-2017, the patient was vaccinated with an expired dose of ROTATEQ lot # M004885, expired on 23-OCT-2017, for prophylaxis (strength, dose and route were not reported). No adverse effect was reported.
Department of Health Services informed pcp office after hours on 9/12/2023. Pt received vaccine in the am prior to office staff being informed of discontinuation of COVID vaccine. No adverse reaction at time of administration. Pt was monitored post vaccine administration as per CDC guidelines.
Incorrect age group--patient received first dose Moderna at age 16 on 3/13/21.  Received second dose Moderna on 4/16/21 as per CDC guidance.  No AE.
experienced rosacea; This case was reported by a consumer via call center representative and described the occurrence of rosacea in an unspecified number of patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rosacea. On an unknown date, the outcome of the rosacea was unknown.   It was unknown if the reporter considered the rosacea to be related to Shingrix.  Additional details were as follows: The age at vaccination was not applicable for this report.  The caller reported that, a couple of her friends experienced rosacea after receiving the Shingrix vaccine. The patient had to be treated with prescription medication to treat the rosacea. The caller reported that, did not have specific patient identifiers. The caller did not feel comfortable providing any specific or additional information about the adverse event reported. The reporter did not consent to follow up.
This is a spontaneous report received from a contactable reporter from medical information team. The reporter is the patient. A 70-year-old female patient received BNT162B2 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunization. The following information was reported: malaise, lethargy and diarrhea, outcome unknown. Additional information: The patient received the second dose on a Saturday, then felt sick on Monday but was better and able to go to yoga class by Tuesday. The patient wanted to know how to get proof of immunization. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Child came in complaining of crippling stomach pain and numbness and pain in both arms. She said she felt weird and off.
Patient had Pneumovax on 08/02.  Fourth day following vaccination, he started having leg pain into his left and into his right leg in the back going down to his size.  Over the next couple of days started with numbness in his feet which then progressed to numbness in his fingertips and hands.  Subsequently he had a fall face forward and hit his head which prompted the hospitalization. Ascending weakness with respiratory compromise and was intubated on 8/18 for obtundation and hypoxemic respiratory failure.
on July 14th, patient had a massive ischemic stroke; no risk factors.  Patient did have COVID infection February 2021
Gave adult dose of Havrix 1440 ELU/ml instead of the pediatric dose of Havrix 720 ELU/0.5 ml
This spontaneous report as received from a physician via company representative refers to a nursing student patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. The patient had received 2 doses of (oka/merck) VARIVAX (lot number, expiration date and dose were not reported). Concomitant medication was not reported. It was reported that the patient's colleague still required titer testing after vaccination and the titer was undetectable. At the time of the report the patient's outcome was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
Diverticulitis confirmed by CT scan, crp 72.91 Esr  95
Pain, redness, and swelling entire upper arm- Day 1. Day 2- Nausea and red and swollen. Day 3-5 Just arm sx improving
First dose of vaccine administered on 1/6/2021 at 1:33pm. Headache and fever started 1/7/2021 around noon.  Reports taking Tylenol to help alleviate symptoms.
Patient called pharmacy 2/14/21 complaining of shoulder pain since got flu shot 12/29/20. Advised to call PCP.
Reported to Pharmacy with swelling and pain at injection site.  Treatment with cold compress, Ibuprofen, and diphenhydramine.  Sent home from work to rest.
High fever; Migraine headache; Achy shoulders; Achy hips; Nausea; Racing heart beat; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 16:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient has no allergies to food, medication or other products. Concomitant medications included biotin (MANUFACTURER UNKNOWN), ascorbic acid (VIT C), zinc (MANUFACTURER UNKNOWN), glucosamine (MANUFACTURER UNKNOWN) and cholecalciferol (VIT D-3) all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 10:00 the patient experienced high fever, migraine head ache, achy shoulders, achy hips, nausea and racing heartbeat. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events high fever, migraine head ache, achy shoulders, achy hips, nausea and racing heartbeat were not recovered at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Upper arm red, swollen and hot to touch. Red streak moves upward to left clavicular area.
Fever (104.5), muscle aches, dizziness, stiffness, severe headache
severe headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced HEADACHE (severe headache). At the time of the report, HEADACHE (severe headache) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. Treatment medicines were not reported.
None-adverse event.  Gardasil #1 given in gluteal area instead of deltoid or lateral thigh.
two days after vaccines, developed fever to 100.9 with crying and diarrhea.  Slowly resolving
This is in follow-up to report (s) previously submitted on 5/16/2008. Information has been received from a health professional concerning a 4 year old female with no pertinent medical history and no known drug reactions/allergies, who on 27-FEB-2008 was vaccinated with a second 0.5 mL subcutaneous dose in the right arm of varicella virus vaccine, live (Oka/Merck) (lot# 659727/1771U). Concomitant vaccination included a second dose in the left arm of M-M-R II, a fourth dose in the right arm of poliovirus vaccine (manufacturer unspecified), and a fifth dose in the left arm of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unspecified). On 27-FEB-2008, 5 to 10 seconds after receiving the varicella virus vaccine live (Oka/Merck) vaccination, she developed a single hive about one inch from the injection site. It was indicated that the single hive was 2 mm. by 2 mm. in diameter. Specific treatment was not reported. It was reported that the hive was still present when the patient left the physician's office. Her vaccination history included on 14-OCT-2004, a first dose of varicella virus vaccine, live (Oka/Merck). A product quality complaint was not reported. A lot check was requested by the reporter. This is one of three reports from the same source.  A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements for the Center for Bilogics Evaluation and Research and was released.
sore arm went on to be pain down left arm extending to left ring finger and middle finger; Pain down my left side ribs, pain over ribs; pain down my back; muscle tightness left side.; Neck pain muscle tightness left side.; cramps muscle pain over chest left rib area; muscle was standing up over 1 inch; pain is mild to extreme; Pain on my left shoulder turned into a muscle pain/cramp shoulder down my back lasting 12 hours; standard sore arm about 4-5 inches below the site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm went on to be pain down left arm extending to left ring finger and middle finger), MUSCULOSKELETAL CHEST PAIN (Pain down my left side ribs, pain over ribs), BACK PAIN (pain down my back), MUSCLE TIGHTNESS (muscle tightness left side.) and NECK PAIN (Neck pain muscle tightness left side.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm went on to be pain down left arm extending to left ring finger and middle finger), MUSCULOSKELETAL CHEST PAIN (Pain down my left side ribs, pain over ribs), BACK PAIN (pain down my back), MUSCLE TIGHTNESS (muscle tightness left side.), NECK PAIN (Neck pain muscle tightness left side.), MUSCLE SPASMS (cramps muscle pain over chest left rib area), SKIN MASS (muscle was standing up over 1 inch), PAIN (pain is mild to extreme), ARTHRALGIA (Pain on my left shoulder turned into a muscle pain/cramp shoulder down my back lasting 12 hours) and VACCINATION SITE PAIN (standard sore arm about 4-5 inches below the site). The patient was treated with METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLON [METHYLPREDNISOLONE SODIUM SUCCINATE]) at a dose of 21 tablets and ORPHENADRINE CITRATE at a dose of 100 milligram. At the time of the report, PAIN IN EXTREMITY (sore arm went on to be pain down left arm extending to left ring finger and middle finger), MUSCULOSKELETAL CHEST PAIN (Pain down my left side ribs, pain over ribs), BACK PAIN (pain down my back), MUSCLE TIGHTNESS (muscle tightness left side.), NECK PAIN (Neck pain muscle tightness left side.), MUSCLE SPASMS (cramps muscle pain over chest left rib area), SKIN MASS (muscle was standing up over 1 inch), PAIN (pain is mild to extreme), ARTHRALGIA (Pain on my left shoulder turned into a muscle pain/cramp shoulder down my back lasting 12 hours) and VACCINATION SITE PAIN (standard sore arm about 4-5 inches below the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
This person is completely vaccinated with Moderna (Dose 1 was received 02/11/2021, Dose 2 was received 03/09/2021).  Patient hospitalized with Covid on 06/11/2021
13 days post vaccine pt dev. macular red rash-face, chest, bilat arms. (+) LAD for shoddy nodes pre-auricular, post-auricular, clavicular and axillary intermittent fevers.
diagnosed with Bells Palsy; This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (diagnosed with Bells Palsy) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-May-2022, the patient experienced BELL'S PALSY (diagnosed with Bells Palsy) (seriousness criterion medically significant). At the time of the report, BELL'S PALSY (diagnosed with Bells Palsy) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medication was reported. It was reported that patient received a moderna shot on 13-May-2022 and went to ER on 17-May-2022 and was diagnosed with Bell's Palsy which is a rare side effect of moderna vax. Patient couldn't talk on phone and patient was slurring words due to the Palsy.  No treatment medications were reported.  Company Comment: This spontaneous case concerns a patient of unspecified age and gender with no reported medical history, who experienced the expected, serious (medically significant) adverse event of special interest Bell's palsy. The event was diagnosed 4 days after receiving a dose of mRNA-1273. The patient had slurring of speech and went to the emergency department for consult. Details of other presenting symptoms, course of the ER visit, diagnostic procedures conducted and medical intervention administered were not provided in the case. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a patient of unspecified age and gender with no reported medical history, who experienced the expected, serious (medically significant) adverse event of special interest Bell's palsy. The event was diagnosed 4 days after receiving a dose of mRNA-1273. The patient had slurring of speech and went to the emergency department for consult. Details of other presenting symptoms, course of the ER visit, diagnostic procedures conducted and medical intervention administered were not provided in the case. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Patient was administed expired Covid-19 Moderna Vaccine. Notified Moderna when we were made on 11/17/21 by . Patient has been called and informed of incident and advised to come in and be given an additional full dose of Covid-19 Moderna Vaccine per the instructions of both Moderna and .
almost fainted; dizzy; was also very shaky; her heart beating really fast; having other symptoms that she don't know if they may be an allergic reaction; This is a spontaneous report from a contactable consumer (Patient herself). A 42 (unspecified unit) old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on 25Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. Patient stated that she received her second COVID-19 vaccine and experienced some other side effects. she does have some medication allergies and allergic to one of the vaccines. After 1 hour of taking the vaccine she was dizzy and almost fainted twice; again after one and half hour later of taking the vaccine she got really dizzy. It happened 2 times right after the vaccine. She said she was also very shaky and her heart beating really fast, now as well. Patient wanted to know if they were allergic reactions. Reporter said she got the second dose of the vaccine yesterday. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient reported that a lump formed in her throat about one hour after receiving the vaccination, which progressed to vomiting about 2 hours later. Patient reports about 3-4 episodes of emesis along with diarrhea.
I received my third Pfizer COVID-19 booster on 11/21/2022. Sometime thereafter, I would experience intermittent pain in the right armpit. This continues to this day. I developed the same issue after having received the four previous Pfizer COVID-19 vaccines and boosters. Last year, when I was being treated for breast cancer, I mentioned the armpit to my radiologist. She said that this issue has been reported by some people after they have received their COVID-19 vaccinations.
Dizziness; Can hardly raise my arm where the shot was given; First dose which I received was Moderna and on April 3rd I received the Pfizer; Dosage was mixed; I got two different shots, I got, the first one was the Moderna and second one wat the Pfizer one; This is a spontaneous report received from a contactable consumer (patient reported for himself/herself). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), first dose via an unspecified route of administration on 03Apr2021 as dose 2 (initial Pfizer dose), single for COVID-19 immunisation; covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration from an unspecified date to an unspecified date, at dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced dizziness can hardly raise my arm where the shot was given, first dose which i received was moderna and on April 3rd i received the Pfizer; dosage was mixed; i got two different shots, i got, the first one was the moderna and second one wat the Pfizer one on an unspecified date. Consumer stated, "I am calling because Saturday I received the second dosage, the first dose which I received was March the 6th which was Moderna (further clarified hence captured as COVID shot). And Saturday on April 3rd I received the Pfizer (further clarified hence captured as COVID shot), not realizing that it was the Pfizer. So, I am calling about, I am having the side effects as in the dizziness and can hardly raise my arm where the shot was given. And I am concerned because the dosage was mixed, so I wanted to know, they did a report on place where they gave the shot, but I did not receive the report and I want to know if they had reported it to you or not.' Consumer stated, 'Yes, because the First shot it was the Moderna, so I got two different shots, I got, the first one was the Moderna and second one wat the Pfizer one. So, I want to know, I just got off the phone with my primary care doctor and they said to go to emergency room, but I wanted to know what other side effects will happen to me taking the first dose of each one and do I need to take the second dose of the Moderna or the second dose of the Pfizer". The outcome of the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a physician refers to a 7 months old patient. It was reported that the patient was 7 months old when the patient was vaccinated with ZOSTAVAX 6 months ago in approximately June 2012. Lot# and route were unspecified. The patient was not experiencing any known symptoms. Additional information has been requested.
Pain in left  wrist, clicking in wrist. Pain in left knee. Pain and weakness in left thumb.  Pain ongoing but improving.